Nasopharyngeal colonization with heptavalent pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae with prolonged vaccine dosing intervals

Pediatric Infectious Disease Journal

Volumn 24, Issue 11, 2005, Pages 969-973

  Jones, Veronnie Faye ^a   Harrison, Christopher ^a   Stout, Gordon G ^a   Hopkins, Jennifer ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Nasopharyngeal colonization; Pneumococcal conjugate vaccine; Streptococcus pneumoniae

Indexed keywords

HEPTAVALENT PNEUMOCOCCUS CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAY CARE; DOSE TIME EFFECT RELATION; DRUG CONJUGATION; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; HIGH RISK POPULATION; HUMAN; INFANT; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NASOPHARYNX; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEROTYPE; STANDARDIZATION; STATISTICAL MODEL; STREPTOCOCCUS PNEUMONIAE;

EID: 28044436050     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000187030.83080.8a     Document Type: Article

References (27)

1. Overturf GD. American Academy of Pediatrics. Technical reports: prevention of pneumococcal infections including use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics. 2000;106:367-376.
2. Dagan R, Melamed R, Muallem M, Piglansky L, Yagupsky P. Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines. J Infect Dis. 1996;174:1352-1355.
3. Sisson BA, Buck G, Franco SM, Goldsmith LJ, Rabalais GP. Penicillin minimum inhibitory concentration drift in identical sequential Streptococcus pneumoniae isolates from colonized healthy infants. Clin Infect Dis. 2000;30:191-194.
4. Hendley JO, Sande MA, Stewart PM, Gwaltney JM. Spread of Streptococcus pneumoniae in families: carriage rate and distribution of types. J Infect Dis. 1975;132:55-61.
5. Principi N, Marchisio P, Schito G C, Mannelli S. The Ascanius Project Collaborative Group. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Pediatr Infect Dis J. 1999;18:517-523.
6. CDC. Progress toward elimination of Haemophilus influenzae type b among infants and children: United States, 1987-1993. MMWR. 1994;43:144-148.
7. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children: Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19:187-195.
8. Black SB, Shinefield HR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002;21:810-815.
9. Whitney CG, Farley MM, Hadler J, et al. Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-1746.
10. Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004;113:617-618.
11. Haddy RI, Perry K, Chacko CE, et al. Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine. Pediatr Infect Dis J. 2005;24:320-323.
12. Dagan R, Muallem M, Melamed R, Leroy O, Yagupsky P. Reduction of nasopharyngeal carriage in early infancy after immunizations with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr Infect Dis J. 1997;16:1060-1064.
13. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis. 1996;174:1271-1278.
14. Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman KP. Immunogenicity and impact on nasopharyngeal carriage of a nanovalent pneumococcal conjugate vaccine. J Infect Dis. 1999;180:1171-1176.
15. Obaro SK, Adegbola RA, Banya WAS, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet. 1996;348:271-272.
16. Lopez B, Cima FV, Vazquez F, et al. Epidemiological study of Streptococcus pneumoniae carriers in healthy primary-school children. Eur J Clin Microbiol Infect Dis. 1999;18:771-776.
17. Fine PE. Herd immunity: history, theory, practice. Epidemiol Rev. 1993;15:265-302.
18. O'Brien K, Dagan R. The potential indirect effect of conjugate pneumococcal vaccines. Vaccine. 2003;21:1815-1825.
19. Herrera GA, Smith P, Daniels D, et al. National, state, and urban area vaccination coverage levels among children aged 19-35 months: United States, 1998. MMWR CDC Surveill Summary. 2000;49:1-26.
20. Ruoff KL, Whiley RA, Beighton D. Streptococcus. In: Murray PR, Baron JE, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. 7th ed. Washington, DC: ASM Press; 1999:283-296.
21. Austrian R. The quellung reaction, a neglected microbiologic technique. Mt Sinai J Med. 1976;43:699-709.
22. Kayhty H, Ahman H, Eriksson K, Sorberg M, Nilsson L. Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age. Pediatr Infect Dis J. 2005;24:108-114.
23. Whitney CG, Pickering LK. The potential of pneumococcal conjugate vaccines for children. Pediatr Infect Dis J. 2002;21:961-970.
24. Lipsitch M. Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis. 1999;5. Available at: http://www.cdc.gov/ncidod/eid/vol5no3/lipsitch.htm. Accessed May 25, 2004.
25. Pelton SI, Klein JO. The promise of immunoprophylaxis for the prevention of acute otitis media. Pediatr Infect Dis J. 1999;61:926-935.
26. Nurkka A, Ahman H, Korkeila M, Jantti V, Kayhty H, Eskola J. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2001;20:25-33.
27. Huang SS, Finkelstein JA, Rifas-Shiman SL, Kleinman K, Platt R. Community-level predictors of pneumococcal carriage and resistance in young children. Am J Epidemiology. 2004;159:645-654.